510(k) · Cleared
ClearedHeartport Endovascular Cardiopulmonary Bypass System Antegrade Sytem (Catalog Number Ecpb-a) Antegrade/Retrograde System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Heartport, Inc. · DXC Clamp, Vascular
Cleared on Sep 30, 1996 as substantially equivalent to K955132 (Heartport, Inc., 1996) and 4 other predicates after a 70-day review. Its family tree reaches back 2 generations to 1981.
- Decided
- Sep 30, 1996
- Review
- 70 days
- Class
- Class II
- Product code
- DXC
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 2 generations to K811411 (1981). 9 ancestors in all, the oldest K810360 (1981). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K811411 | Swan-Ganz Heparin Coated, Etc. Catheter | American Edwards Laboratories | 1981 | — |
| −1 | K961245 | Heartport Endopulmonary Vent | Heartport, Inc. | 1996 | — |
| 0 (this device) | K962858 | Heartport Endovascular Cardiopulmonary Bypass System Antegrade Sytem (Catalog… | Heartport, Inc. | 1996 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1981 | 1 | 0 |
| 1985 | 1 | 0 |
| 1988 | 1 | 0 |
| 1990 | 1 | 0 |
| 1996 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DXC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DXC device
- #1 K262086 PreludeSYNC™ Radial Compression Devicescore 13.5 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K955132 | Heartport Endoaortic ClampSummary page 1…ular Antegrade Cardiopulmonary Bypass System is composed of the following commercially available bypass catheters, cannulae and accessories: Heartport Endoaortic Clamp (K955132) Heartport Endopulmonary Vent (K961245) Heartport Endoarterial Return Cannula (K955121) Medtronic DLP Venous Drainage Cannula… | 1996 |
| * | K961245 | Heartport Endopulmonary VentSummary page 1…stem is composed of the following commercially available bypass catheters, cannulae and accessories: Heartport Endoaortic Clamp (K955132) Heartport Endopulmonary Vent (K961245) Heartport Endoarterial Return Cannula (K955121) Medtronic DLP Venous Drainage Cannula (K875353) or a substantially equivalent… | 1996 |
| * | K955121 | Heartport Endoarterial Return CannualSummary page 1…ailable bypass catheters, cannulae and accessories: Heartport Endoaortic Clamp (K955132) Heartport Endopulmonary Vent (K961245) Heartport Endoarterial Return Cannula (K955121) Medtronic DLP Venous Drainage Cannula (K875353) or a substantially equivalent Heartport manufactured device The Heartport Endo… | 1996 |
| * | K875353 | Percutaneous Arterial/Venous Cannula Placement KitSummary page 1…s: Heartport Endoaortic Clamp (K955132) Heartport Endopulmonary Vent (K961245) Heartport Endoarterial Return Cannula (K955121) Medtronic DLP Venous Drainage Cannula (K875353) or a substantially equivalent Heartport manufactured device The Heartport Endovascular Antegrade/Retrograde Cardiopulmonary Byp… | 1988 |
| * | K961270 | Heartport Endosinus CatheterSummary page 1…device The Heartport Endovascular Antegrade/Retrograde Cardiopulmonary Bypass System consists of the above Antegrade Kit in addition to: Heartport Endosinus Catheter (K961270) Heartport, Inc. CONFIDENTIAL 10 Endovascular Cardiopulmonary Bypass Systems Appendices Intended Use: The Hear… | 1996 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 15 years and passes through 2 companies; a new generation was cleared every 15.0 years on median.
- 3 of the 9 ancestors have a recall of any class.
- 2 other devices also cite its predicate K955132.
How does its category compare?
All DXC devicesDXC Clamp, Vascular: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DXC
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DXC
215in 2023
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DXC
2in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DXC
442in 2025
MAUDE reports naming product code DXC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 10 | 52 | 0 | 298 |
| 2008 | 3 | 29 | 2 | 302 |
| 2009 | 4 | 83 | 2 | 539 |
| 2010 | 2 | — | 1 | 600 |
| 2011 | 6 | 51 | 3 | 691 |
| 2012 | 5 | 73 | 0 | 548 |
| 2013 | 14 | 89 | 0 | 920 |
| 2014 | 4 | 157 | 1 | 494 |
| 2015 | 5 | 71 | 0 | 374 |
| 2016 | 3 | 91 | 0 | 494 |
| 2017 | 3 | 90 | 0 | 416 |
| 2018 | 2 | — | 0 | 391 |
| 2019 | 2 | — | 0 | 393 |
| 2020 | 3 | 209 | 0 | 404 |
| 2021 | 6 | 37 | 0 | 371 |
| 2022 | 1 | — | 1 | 273 |
| 2023 | 4 | 215 | 2 | 674 |
| 2024 | 1 | — | 0 | 375 |
| 2025 | 2 | — | 0 | 442 |
| 2026 | 4 | 125 | 0 | — |
What is it indicated for?
The Heartport Endovascular Cardiopulmonary Bypass Systems are indicated for use in patients undergoing cardiac surgery requiring cardiopulmonary bypass and an arrested heart. The system consists of a set of catheters, cannulae and accessories that permits a patient to be maintained on cardiopulmonary bypass and the patient’s heart to be arrested without the need for a median sternotomy.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K962858 · printed Nov 4, 2026
Cite this page
510(k) Report. “K962858: Heartport Endovascular Cardiopulmonary Bypass System Antegrade Sytem (Catalog Number Ecpb-a) Antegrade/Retrograde System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K962858
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026